Boston An independent LDT provider
NOTE:Immunovia has ceased commercialization of the IMMray PanCan-d test. More information available here:

Sustainability report

This sustainability report refers to financial year 2021 and applies to the parent company Im­munovia AB (Publ.) (org. no.556730-4299) and all entities consolidated in Immunovia’s conso­lidated accounts for the same period. These are stated in Note 21 of the Annual Report 2021. This report has been prepared without Immunovia having any legally mandatory requirement to do so and is not based on any specific sustainability standard but is based on the regulations of the Annual Accounts Act.

Sustainability Report